Publications

Litigation Packet

Litigation Packet

Risperdal

Pages1898
CreatedMar 31, 2015
$325.00
Delivery method: Download
  • Risperdal, an atypical (second generation) antipsychotic originally approved for the treatment of schizophrenia and Bipolar I disorder in adults but marketed off-label to children and adolescents, can increased prolactin levels and cause irreversible gynecomastia
  • Includes case screening criteria, a sample complaint, and an overview of litigation
  • Includes pleadings and orders from three mass tort actions in Pennsylvania, New Jersey, and California
  • AAJ Education speaker papers, resources from the U.S. Food and Drug Administration, and a survey of medical journal articles